Ovarian Cancer Pathology and Classification

Ovarian cancer remains the most lethal gynecologic malignancy, primarily because it is often diagnosed at an advanced stage. Understanding its complex pathology is the first step toward early detection and targeted treatment.

The Foundation: Three Main Histologic Lineages

Ovarian tumors are classified based on the cell type from which they originate. This system creates three broad, clinically essential categories: epithelial tumors, germ cell tumors, and sex cord-stromal tumors. Epithelial tumors arise from the surface lining of the ovary, germ cell tumors from the egg-producing cells, and sex cord-stromal tumors from the ovary's hormone-producing structural framework. This lineage dictates everything from the patient's age at presentation to the tumor's growth pattern, secreted markers, and metastatic potential.

Epithelial Ovarian Tumors: The Most Common and Deadly

Epithelial ovarian tumors constitute over 90% of all ovarian cancers and are responsible for the majority of ovarian cancer deaths. They are further subdivided by their microscopic appearance and the type of fluid or tissue they produce.

• Serous Tumors: These are the most common epithelial tumors. Serous cystadenocarcinoma is the most frequent malignant type. These tumors often form large, complex cystic masses filled with watery fluid. They are aggressive and frequently bilateral (affecting both ovaries). A key clinical correlate is their association with elevated levels of the tumor marker CA-125, which is used for monitoring disease progression and response to therapy.
• Mucinous Tumors: These tumors are characterized by cysts filled with thick, gelatinous mucus. While often benign, malignant mucinous carcinomas can become very large and may be associated with a condition called pseudomyxoma peritonei if they rupture and spread within the abdominal cavity.
• Endometrioid Tumors: These carcinomas resemble the lining of the uterus (endometrium) and are frequently associated with endometriosis. They can sometimes occur synchronously with endometrial cancer in the uterus.

A critical risk factor for high-grade serous ovarian carcinoma is inherited mutations in the BRCA1 and BRCA2 genes. These tumor suppressor genes are involved in DNA repair; mutations significantly increase lifetime risk, not only for ovarian cancer but also for breast cancer. This knowledge directly impacts clinical practice, guiding genetic counseling and prophylactic surgical decisions for at-risk individuals.

Germ Cell Tumors: Tumors of Young Women

Germ cell tumors originate from the primitive egg cells (oocytes) and typically occur in children, adolescents, and young women. They are much rarer than epithelial tumors but are often highly curable, even when malignant.

• Dysgerminoma: This is the ovarian counterpart to testicular seminoma. It is the most common malignant germ cell tumor. Dysgerminomas are sensitive to both chemotherapy and radiation, leading to excellent survival rates. They can secrete lactate dehydrogenase (LDH), which serves as a useful tumor marker.
• Mature Teratoma: Also known as a dermoid cyst, this is the most common ovarian germ cell tumor overall. It is benign and contains well-differentiated tissues from all three embryonic germ layers (ectoderm, mesoderm, endoderm), which can include hair, teeth, bone, and sebaceous material. Immature teratomas, containing poorly differentiated tissues, are malignant.

Sex Cord-Stromal Tumors: The Hormone Producers

Sex cord-stromal tumors arise from the ovary's supporting tissue and hormone-producing cells. They are notable for their endocrine activity, often producing symptoms related to hormone excess.

• Granulosa Cell Tumor: This tumor produces estrogen. In premenopausal women, this can lead to menstrual irregularities or early puberty. In postmenopausal women, it often causes vaginal bleeding due to endometrial stimulation, which can be a crucial diagnostic clue. These tumors are typically low-grade but have a tendency for late recurrence.
• Sertoli-Leydig Cell Tumor: This rare tumor produces androgens (male hormones). Clinical presentation often includes signs of virilization, such as hirsutism (excess hair growth), deepening of the voice, and clitoromegaly. The hormonal effects provide a direct link between the tumor's pathology and the patient's symptoms.

Common Pitfalls

1. Assuming "Ovarian Mass" Means Epithelial Cancer: In a young woman, an ovarian mass is statistically more likely to be a benign functional cyst or a germ cell tumor (like a mature teratoma) rather than an epithelial carcinoma. Failing to consider age and tumor type can lead to unnecessary radical surgery.
2. Overlooking Hormonal Symptoms: Attributing new-onset hirsutism or postmenopausal bleeding solely to non-cancerous causes without imaging the ovaries can delay the diagnosis of a sex cord-stromal tumor. These hormonal signs are direct clues to the tumor's pathology.
3. Misinterpreting Tumor Markers: CA-125 is elevated in many conditions, including endometriosis, pelvic inflammatory disease, and even pregnancy. Using it as a standalone screening tool leads to false positives. Its primary utility is in monitoring known disease. Conversely, failing to check LDH in a young woman with a solid ovarian mass could miss a dysgerminoma.
4. Neglecting Family History: Not taking a thorough family history of breast and ovarian cancer can mean missing patients with BRCA1/BRCA2 mutations who are at profoundly increased risk. This history is vital for both diagnosis in the patient and risk assessment for family members.

Summary

• Ovarian tumors are classified into three lineages: epithelial (most common and deadly), germ cell (common in young women, often curable), and sex cord-stromal (hormone-producing).
• Serous cystadenocarcinoma is the most common malignant epithelial tumor, associated with elevated CA-125 and a high risk linked to BRCA1 and BRCA2 germline mutations.
• Key germ cell tumors include dysgerminoma (malignant, LDH marker) and mature teratoma (benign dermoid cyst).
• Sex cord-stromal tumors cause symptoms via hormone secretion: Granulosa cell tumors produce estrogen (causing bleeding), while Sertoli-Leydig cell tumors produce androgens (causing virilization).
• Clinical presentation varies dramatically by tumor type, emphasizing the need for a diagnosis that integrates pathology, patient age, family history, and laboratory findings.